Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease (Q39863620)
Jump to navigation
Jump to search
scientific article published on April 2009
- EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease |
scientific article published on April 2009 |
|
Statements
1 reference
Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease (English)
1 reference
Jeffrey H Kordower
1 reference
Christopher D Herzog
1 reference
Lamar Brown
1 reference
Dawn Gammon
1 reference
Brian Kruegel
1 reference
Richard Lin
1 reference
Alistair Wilson
1 reference
Ariadne Bolton
1 reference
Marie Printz
1 reference
Mehdi Gasmi
1 reference
Kathie M Bishop
1 reference
Raymond T Bartus
1 reference
1 April 2009
1 reference
1 reference
602-12; discussion 612-3
1 reference
Identifiers
1 reference